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Oct-4Abstract Triapine, the most studied a-N-heterocyclic thiosemicarbazone, revealed potent activity
against advanced leukemia, but was ineffective against a variety of solid tumors. Moreover, methe-
moglobinemia, which is a side effect of triapine administration, may limits all clinical application.
To enhance anticancer activity and reduce side effects, we applied an isosteric replacement of sulfur
to selenium atom was performed by synthesis and characterization of selenium triapine analog,
3-aminopyridine-2-carboxaldehyde selenosemicarbazone (selenotriapine). Compared to triapine,activity,
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low toxicity and ability to challenge phenoty
10.1016/j.arabjc.2017.11.017selenotriapine revealed superior pro-apoptotic activity with activation of intrinsic apoptotic path-
way in both human monocytic leukemia (THP-1) and mammary adenocarcinoma (MCF-7) cell
lines. For MCF-7 2-D cultures, selenotriapine induced notable increase in mitochondrial superoxide
radical generation and dissipation of mitochondrial transmembrane potential. A significant delay in
growth of MCF-7 spheroids (3-D culture) was accompanied by phenotypic stem cell reprogram-
ming (Oct-4 expression). Additionally, selenotriapine demonstrated a very low toxicity profile as
compared to triapine, confirmed over alleviated extent of methemoglobin formation and higher
IC50 value in brine shrimp cytotoxicity assay.
 2017 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Anticancer properties of a-N-heterocyclic thiosemicarbazones,
known tridentate N,N,S chelators, were studied starting from
the late 1960s (French et al., 1974). After it was shown that
5-hydroxy-2- carboxaldehyde thiosemicarbazone (5-HP), the
first thiosemicarbazone which entered phase I clinical trials,
possesses minimal antileukemic activity (DeConti et al.,
1972), in order to find more potent drug candidates multiple
novel 5-HP derivatives have been developed. From a group
of pyridine-substituted thiosemicarbazones, 3-aminopyridine-
2-carboxaldehyde thiosemicarbazone (Triapine, 3-AP)
emerged as the most potent anticancer compound against
mouse lymphocytic leukemia (L1210) cells (Cory et al., 1994,
1995; Finch et al., 2000; Liu et al., 1992, 1996). In vitro activity
of 3-AP has been observed in leukemia, non-small-cell lung
cancer, renal cancer, and melanoma cell lines (Schelman
et al., 2009). 3-AP has been the most studied
thiosemicarbazone-based anticancer agent with more than 30
clinical phase I and phase II trials. First mechanistic studies
showed that 3-AP exerts its antineoplastic activity by inhibit-
ing DNA synthesis and repair, and it was recognized as a
potent small molecule ribonucleotide reductase (RR) inhibitor
(Cory et al., 1994). Human RR is tetramer complex composed
of two non-identical homodimers, hRRM1 and hRRM2,
responsible for the reduction of ribonucleotides to deoxyri-
bonucleotides. The large subunit hRRM1 harbors the catalytic
site, allosteric effector-binding sites, and redox active disulfides
that participate in the reduction of substrates, whereas the
small subunit hRRM2 contains an oxygen-linked di-ferric cen-
ter and one tyrosyl radical per monomer that are essential for
enzymatic activity. A protein p53R2 is 80% hRRM2 homolog
which plays a crucial role in supplying deoxyribonucleotides
for DNA repair (Shao et al., 2004; Aggarwal et al., 2007).
There are two pathways in human cells to supply deoxyribonu-
cleotides for DNA synthesis: one through the activity of
hRRM2 involved in normal maintains of deoxyribonu-
cleotides for DNA replication during the S-phase in a cell cycle
dependent manner, and the other one through p53R2, supply-
ing deoxyribonucleotides for DNA repair during G0/G1 phase
that is p53 dependent (Shao et al., 2004). RR plays a funda-
mental role in the critical early events involved in tumor pro-
motion and its activity is tightly linked to the neoplastic
expression state and is currently one of the main targets for
DNA inhibition by anticancer agents (Moorthy et al., 2013).
Sartoreli et al. revealed that 3-AP inhibits incorporation of
[3H] thymidne into DNA while incorporation of cytidine into
DNA via RR was markedly inhibited, thus a pronounced.R. et al., Selenotriapine – An isostere
pe reprogramming of 3-D mammary adecrease in the formation of [14C] deoxyribonucleotides from
radioactive cytidine occurs in the acid-soluble fraction of 3-
AP-treated L1210 cells (Cory et al., 1994). Later it was shown
that 3-AP is equally potent inhibitor of hRRM2 and p53R2,
which was not the case for other chelating agents (Shao
et al., 2004). The following mechanisms of RR inhibition by
3-AP, based on inactivation of its active site, have been pro-
posed: (1) direct destruction of active site by Fe(III) chelation;
(2) indirect destruction of active site by Fe(II)-3-AP complex
obtained by the reaction of 3-AP with iron from cellular
pool(s); (3) indirect destruction of active site by reactive oxy-
gen species (ROS) generated during reaction of dioxygen with
Fe(II)-3-AP obtained from reduction of Fe(III)-(3-AP) by
endogenous reductants; (4) direct reduction of tyrosyl radical
by Fe(II)-(3-AP) complex without ROS formation; (5) endo-
plasmic reticulum stress induction; (6) mitochondrial ROS
production (Aye et al., 2012; Myers, 2016; Myers et al.,
2011; Trondl et al., 2014). It is still not completely elucidated
if there is a prevailing source of iron that is particularly suscep-
tible for chelating reaction with 3-AP. Recent studies have
revealed that there is no formation of Fe(III)-3-AP in blood
and 3-AP is not able to sequester iron from iron-binding pro-
teins such as holo-transferrin or hemoglobin (Pelivan et al.,
2016), while the transiently increased ferritin levels indicate
that the interaction of 3-AP with iron occurs in the liver which
is known as the site of ferritin production (Wadler et al., 2004).
Despite the fact that 3-AP showed promising activity
against advanced leukemia in clinical phase I trials, several
clinical phase II studies revealed that 3-AP is ineffective
against a variety of solid tumors, indicating increased expres-
sion of multidrug-resistance proteins as the main cause
(Heffeter et al., 2012). Side effects associated with 3-AP admin-
istration are hypoxia and methemoglobinemia, resulting from
the oxidation of oxyhemoglobin (oxyHb) to methemoglobin
(metHb), which limit its clinical application considering it
can compromise cardiopulmonary function of patients. The
ability of 3-AP to form a redox active iron complex is an
important factor in the formation of metHb (Quach et al.,
2012). In order to deal with 3-AP side effects, to understand
its mechanism of action in more detail and to improve its effi-
cacy, various strategies have been employed such as manage-
ment of methemoglobinemia by supplemental oxygen and
intravenous administration of therapeutic antidotes (Kunos
et al., 2012), synthesis of various 3-AP derivatives (Cory
et al., 1994; Kowol et al., 2016; Quach et al., 2012; Stefani
et al., 2013), and synthesis of d-metal complexes with 3-AP
as a ligand (Basha et al., 2016; Enyedy et al., 2010, 2011;
Ishiguro et al., 2014; Myers et al., 2013; Pelivan et al., 2016).of the most studied thiosemicarbazone with pronounced pro-apoptotic activity,
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tigated to a much smaller extent due to controversial about
selenium impact on health. First, this element was marked as
toxic, but in 1980s was found to be essential in humans
(Combs Jr., 2015). Despite the fact that selenium chemistry
is more similar to sulfur than to oxygen, the difference between
two heavier chalcogens is particularly pronounced in terms of
redox behavior, which has been referred as the selenium para-
dox. As comparative studies showed, the nature of chalcogen
atom has a great impact on biological activity of isosteric
selenosemicarbazones and thiosemicarbazones (Al-Eisawi
et al., 2016; Calcatierra et al., 2015; Klayman et al., 1983;
Kowol et al., 2012; Mautner et al., 1956; Molter et al., 2011;
Pizzo et al., 2012; Revenko et al., 2011). Both classes of com-
pounds equally inhibit herpes simplex virus type-1 ribonucle-
oside diphosphate reductase (Turk et al., 1986).
Thiosemicarbazones were found to be more effective antineo-
plastic and antimalaric agents than selenosemicarbazones
(Klayman et al., 1983), which on the other hand are more
selective toward neoplastic cells relative to normal ones (Al-
Eisawi et al., 2016). Selenium compounds also showed better
antiproliferative and antimicrobial activity, plus superior
cruzipain inhibition when compared to the sulfur analogues
(Mautner et al., 1956; Pizzo et al., 2012; Revenko et al.,
2011). Our recent study showed that selenium compounds
are less toxic in comparison to their sulfur analogues
(Filipovic et al., 2017). Selenosemicarbazones also coordinate
iron in a tridentate fashion and consequently they are capable
to inhibit RR (Agrawal et al., 1974; West et al., 1985). ROS
production, oxidative stress as well as mitochondrial mem-
brane disruption and lysosomal membrane permeabilization
are found to be involved in the mechanism of cytotoxic activity
of selenosemicarbazones (Filipovic et al., 2016). Our recent
study demonstrated that this class of compounds possess
strong differentiation-inducing ability (Todorovic et al., 2017).
In this work, isosteric replacement of sulfur to selenium
atom was performed by synthesis and characterization of sele-
nium analog of 3-AP, 3-aminopyridine-2-carboxaldehyde
selenosemicarbazone (Se-3-AP). Our investigations provide
information on how malignant in vitro biological models are
affected by the treatment with Se-3-AP. The pro-apoptotic
activities of both compounds were tested in parallel on two
human cell lines: an acute monocytic leukemia (THP-1) and
a mammary adenocarcinoma (MCF-7) cell lines. Activity of
3-AP has been evaluated against leukemia (Cory et al., 1994;
Finch et al., 1999, 2000; Karp et al., 2008; Trondl et al.,
2014), but published results on THP-1 cells harboring mutated
p53 are still missing (Leitch et al., 2016). 3-AP was also inves-
tigated for the treatment of breast cancer in two clinical trials
(Mortazavi et al., 2013; Schelman et al., 2009), whereas in vitro
results of its activity on MCF-7 cells with wild-type p53 was
determined by means of colorimetric assay after 6 day incuba-
tion (Jordheim et al., 2005). Relying on previous reports that
showed 3-AP-mediated inhibition of RR abrogates homolo-
gous recombinant repair (HRR) (Lin et al., 2014), we chose
cell lines with different p53 status as a good model to compare
modes of 3-AP and Se-3-AP activities. A body of evidences
revealed that wild-type p53 suppresses HRR activity, whereas
in cells that express mutated p53 activity of HRR is stimulated
although not statistically significant compared to those withPlease cite this article in press as: Filipovic´, N.R. et al., Selenotriapine – An isostere
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Wiesmuller, 2006; Liu et al., 2010; Mekeel et al., 1997;
Ratner et al., 2016). Additionally, we investigated activity of
Se-3-AP on 3-D spheroid model, which according to its archi-
tecture well mimics in vivo tumor mass in a function of multi-
ple parameters (Lin and Chang, 2008), particularly due to
recognized feature of breast cancer cell lines to re-establish
phenotypic equilibrium of the parental tumor (Gupta et al.,
2011). Toxicity profile of both compounds regarding metHb
formation and Artemia salina lethality assay was also
analyzed.
2. Experimental
2.1. Reagents and instrumentation
tert-Butyl (2-formylpyridin-3-yl)carbamate and 3-AP were
synthesized according reported procedures (Kowol et al.,
2009). All other chemicals and solvents (reagent grade) were
obtained from commercial suppliers and used without further
purification. Elemental analyses (C, H, N) were performed by
the standard micromethods using the ELEMENTAR Vario
EL III CHNS/O analyzer at Center for Instrumental Analysis,
Faculty of Chemistry – University of Belgrade. Elemental
analyses are within ±0.4%, confirming >95% purity. IR
spectra were recorded on a Thermo Scientific Nicolet 6700
FT-IR spectrophotometer by the Attenuated Total Reflection
(ATR) technique in the region 4000–350 cm–1. Abbreviations
used for IR spectra: vs very strong; s, strong; m, medium; w,
weak. The NMR spectra were performed on a Bruker Avance
500 equipped with broad-band direct probe. Chemical shifts
are given on d scale relative to tetramethylsilane (TMS) as
internal standard for 1H and 13C, or indirect referencing to
TMS as 1H standard for 77Se. All spectra were measured at
298 K. Abbreviations used for NMR data: s, singlet; m, multi-
plet; py, pyridine; Cq, py = pyridine quaternary carbon atom.
pH values were measured using a CRISON pH-Burette 242S
equipped with a CRISON 50 29 micro-combined pH electrode
(CRISON INSTRUMENTS, S.A. Spain). For acidity con-
stants determination, UV/vis spectra were recorded on a
Thermo Scientific Evolution 60S spectrophotometer (Thermo
Fisher Scientific Inc, Waltham, Massachusetts, USA) using a
quartz cell with 1.0 cm path length. For DPPH scavenging
activity, absorbance at 517 nm was measured using a Thermo
Scientific Appliskan. Anticancer related experiments were per-
formed on Guava easyCyte 12HT Benchtop flow microcap-
illary cytometer (EMD Millipore, Darmstadt, Germany) using
the InCyte software package (EMD Millipore, Cat. No.
0500-4120). A Submarine Mini-gel Electrophoresis Unit
(Hoeffer HE 33) with an EPS 300 power supply was used for
DNA cleavage studies. The stained gel was illuminated under
a UV trans illuminator Vilber-Lourmat (France) at 312 nm
and photographed with a Nikon Coolpix P340 Digital Camera
through filter Deep Yellow 15 (Tiffen, USA). For HSA bind-
ing experiments UV/vis spectra were recorded on a UV-1800
Shimadzu spectrophotometer (Shimadzu, Japan) equipped
with thermostat bath, against the corresponding blank (0.1
M PBS pH 7.4) in the range 250–450 nm. The fluorescence
measurements were performed on a FluoroMax-4 Jobin Yvon
(Horiba Scientific, Japan) spectrofluorometer equipped withof the most studied thiosemicarbazone with pronounced pro-apoptotic activity,
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emission slit widths were set to 6.5 nm.
2.2. Synthesis of 3-aminopyridine-2-carbaldehyde
selenosemicarbazone (Se-3-AP)
To a mixture of tert-butyl (2-formylpyridin-3-yl)carbamate
(1.468 g, 6.61 mmol) and selenosemicarbazide (662 mg, 7.27
mmol) in EtOH/H2O solvent mixture (22.5 mL, 67% v/v), 3
mL of conc. HCI was added. The resulting solution was
refluxed for 3 h, cooled down to a room temperature (RT)
and resulting precipitate was filtered of. The crude yellowish
Se-3-AP  HCl was transferred into a flask and 40 mL of
hot water and 10% aq. NaHCO3 (8 mL) was added. The mix-
ture was stirred at RT for 1 h (at pH 7.0). The crude product
was filtered of and washed with water (10 mL), EtOH (3 mL)
and Et2O (10 mL). The obtained solid was dried under high
vacuum for a few hours. Yield: 0.28 g (66%). Anal. Calcd.
for C7H9N5Se (Mr 242.14): C, 34.72; H, 3.75; N, 28.92. Found:
C, 34.52; H, 3.61; N, 28.90%. UV/vis (DMSO), kmax, nm (e,
M1 cm1): 316 (5947), 393 (21248). IR (ATR, cm–1): 3398
(vs), 3300 (vs), 1626 (vs), 1542 (s), 1451 (s), 1366 (m), 1318
(w), 1266 (s), 1147 (m), 1053 (w), 803 (w), 749 (w). 1H NMR
(500 MHz, DMSO d6): d 11.57 (s, 1H, NANH), 8.58 (s, 1H,
Se‚CANH2), 8.45 (s, 1H, Se‚CANH2), 8.43 (s, 1H,
HC‚N), 7.84 (s, 1H, Hpy), 7.19–7.04 (m, 2H, Hpy), 6.47 (s,
2H, NH2).
13C NMR (126 MHz, DMSO d6): d 172.33 (C‚Se),
150.61 (C‚N), 144.17 (Cq, CpyCH), 137.28(Cpy), 132.45 (Cq,
CpyNH2), 124.69 (Cpy), 122.37 (Cpy).
77Se NMR (95 MHz,
DMSO d6): d 203.50.
2.3. Cyclic voltammetry
The cell (10 mL) consisted of three-electrode system: glassy
carbon electrode (inner diameter of 3 mm; CHI 104), an Ag/
AgCl (saturated KCl) reference electrode and Pt counter elec-
trode. The potential was swept over the range from 2.0 to
+1.2 V (vs. Ag/AgCl) at scan rate of 100 mV s1. Measure-
ments were performed at RT with deaeration by passing a
stream of nitrogen through the solution for 5 min prior to
the measurement and then maintaining a blanket atmosphere
of nitrogen over the solution during the measurements. The
potentials were measured in 0.10 M tetrabutylammonium hex-
afluorophosphate/DMSO, and are quoted relative to Ag/AgCl
reference electrode.
2.4. Determination of acidity constants
Acidity constants of Se-3-AP were determined by spectropho-
tometric titration at t= 25 ± 1 C. Working solution (c=
0.031 mM) was prepared by dissolving accurately weighted
dried Se-3-AP in 5 mL of DMSO; 10 mM phosphate buffer
(pH 1.77, I= 0.1 M NaCl) was added up to 100 mL. First,
pH value was adjusted to 1.65 with conc. HCl, than small vol-
ume increments of 1 M KOH were added stepwise, until pH
11.88 was reached (total volume change at the end of the titra-
tion was lower than 2%). During titration, after each pH value
equilibration, pH values were continuously measured and UV/
vis spectra were recorded. The spectra were recorded at follow-
ing pH values: 1.73, 1.98, 2.25, 2.50, 2.82, 3.19, 3.70, 3.89, 4.09,Please cite this article in press as: Filipovic´, N.R. et al., Selenotriapine – An isostere
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10.20, 10.50, 10.95, 11.41, 11.88, against the phosphate buffer
as a blank. The pH electrode was calibrated by standard CRI-
SON buffer solutions (pH 4.01, 7.00, and 9.21). Acidity con-
stants were calculated according to transformed forms of
classical spectrophotometric equations (Albert and Serjeant,
1984).
2.5. Free radical scavenging antioxidant assay
The proton donating ability of Se-3-AP and 3-AP was assayed
using a protocol for the determination of radical scavenging
activity (Prior et al., 2005). Compounds were dissolved in pure
DMSO and were diluted into ten different concentrations.
Commercially available free radical DPPH was dissolved in
methanol at a concentration of 6.58  10–5 M. Into a 96-well
microplate, 140 mL of DPPH solution was loaded and 10 mL
DMSO solution of the tested compounds was added, or pure
DMSO (10 mL) as the control. The microplate was incubated
for 30 min at 298 K in the dark and the absorbance was mea-
sured at 517 nm. All the measurements were carried out in trip-
licate. The scavenging activity of the compounds was
calculated using Eq. (1):
Scavenging activityð%Þ ¼ ½ðAcontrol AsampleÞ=Acontrol  100
ð1Þ
where Asample and Acontrol refer to the absorbance at 517 nm of
DPPH in the sample and control solutions, respectively.
IC50 values were calculated from the plotted graph of scav-
enging activity against the concentrations of the samples. IC50
is defined as the total antioxidant concentration necessary to
decrease the amount of the initial DPPH radical by 50%.
IC50 was calculated for all compounds based on the percentage
of DPPH radicals scavenged. Vitamin C was used as the refer-
ence compound (positive control) with concentrations 50–500
lg  mL–1.
2.6. Cell cultures
Human mammary adenocarcinoma (MCF-7, ATCC HTB-
22) cell line was maintained in Dulbecco’s Modified Eagle’s
high glucose Medium (DMEM, Dominique Dutscher, 67172
Brumath cedex, France, Cat No L0102-500), while human
acute monocytic leukemia cell line (THP-1, ATCC TIB-
202) was maintained in Roswell Park Memorial Institute
1640 medium (RPMI-1640, Life Technologies, Paisley, UK,
Cat. No. 11875-093), supplemented with 10% (v/v) heat inac-
tivated fetal bovine serum (FBS, Life Technologies, Paisley,
UK, Cat No 10270-106) and 1% (v/v) penicillin-
streptomycin (10,000 U/mL and 10,000 mg/mL Life Technolo-
gies, Paisley, UK, Cat No 15140-122). Cells were kept at 37 C
in humidified atmosphere containing 5% (v/v) CO2 during
their exponential growing phase and in the course of incuba-
tion with investigated compounds. Investigated compound
was initially dissolved in DMSO to the stock concentration
of 20 mM. Further dilutions to the experimental concentra-
tions applied on the cells have been done with RPMI-1640
or DMEM media immediately before each experiment, thus
the final concentration of DMSO on cells treated with the
highest applied concentration was 0.5% (v/v).of the most studied thiosemicarbazone with pronounced pro-apoptotic activity,
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Cells were seeded in 96 flat bottom well plates (Corning
Costar, Cat. No. CLS3596) in a volume 0.1 mL, at a density
of 10,000 per well. MCF-7 cells were left overnight to settle,
while treatment of THP-1 cells started 2 h after seeding. Inves-
tigated compounds were added in a range of six concentra-
tions. As controls, non-treated cells, cells treated with 0.5%
DMSO, and cells treated with Celastrol (Enzo Life Sciences,
Cat. No. ALX-350-332-M025) at 50 mM concentration were
used. After 24 h of incubation, from wells with treated
MCF-7 cells supernatant medium with non-adherent cells were
removed into another 96 well plate. Fresh PBS was added to
remaining adherent cells afterwards the plate was centrifuged
at 450g for 10 min. Supernatant was discarded and 200 mL
of trypsin-EDTA (BioWest, Nuaille, France, Cat No L0930-
100) was added to each well. Cells were detached in about
15 min of incubation at 37 C. Trypsin-EDTA was removed
after additional spinning cycle, afterwards previously removed
supernatants with non-adherent cells were added to trypsinized
cells and stained with Annexin V-FITC (Immuno Tools, Frie-
soythe, Germany, Cat No 31490013) and PI (Miltenyl Biotec
Inc, Auburn, USA, Cat No 130-093-233) in volumes of 3
mL. In the case of THP-1 cells, Annexin V-FITC and PI were
added to the wells with cells right after the incubation time was
over. Described trypsinization protocol was applied each time
MCF-7 cells were prepared for flow cytometry analyses, unless
is stated otherwise. Plates were analyzed and classified accord-
ing to AnnexinV-FITC (green fluorescence) and PI (red fluo-
rescence) labeling on viable (double negative), pre-apoptotic
cells (Annexin V-FITC single-stained cells), necrotic cells (PI
single-stained cells), and cells in advanced phases of apoptosis
(double-stained cells).
2.8. ED50 determination
Percentages of Annexin V single-stained and double-stained
cells were summarized for each concentration of investigated
compound. The computed percentages were potted against
corresponding concentrations on a concentration-response
graph. ED50 concentration was calculated as the one that cor-
responds to a half-way of the sigmoidal concentration-
dependent curve using asymmetric five-parameter logistic
equation (GraphPad Prism 6 software).
2.9. Cell cycle analysis
Distribution of cells within phases of mitotic division has been
evaluated on remaining cells after Annexin V-FITC/PI analy-
sis. Right after pro-apoptotic read out was finished, cells were
fixed in EtOH overnight at 4 C, and afterwards stained with
FxCycle PI/RNAse Staining solution (Molecular Probes,
Cat. No. F10797), and analyzed on a microcapillary flow
cytometer.
2.10. Inhibition of caspase activity
Cells were treated with investigated compound at ED50 con-
centration for 6 h with or without pan-caspase inhibitor
Z-VAD-fmk (Promega, Madison, USA, Cat. No. G7232). AsPlease cite this article in press as: Filipovic´, N.R. et al., Selenotriapine – An isostere
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and cells treated with ED50 concentration only were used.
After incubation period was ended, treated cells were carried
out for Annexin V/PI staining as described above, and ana-
lyzed on a cytometer. The percent of apoptosis inhibited by
Z-VAD-fmk co-treatment was determined by Eq. (2):
apoptosis inhibitionð%Þ
¼ ½1ð% of apoptosis in A=% of apoptosis in BÞ100 ð2Þ
where A is the sample treated with Z-VAD-fmk and investi-
gated compound applied at ED50 concentration, while B is
the corresponding sample treated with investigated compound
at ED50 concentration only.
2.11. Evaluation of caspase-8 and -9 activities
Cells were treated with investigated compound at ED50 con-
centration for 6 h afterwards activity of caspase-8 and -9 were
assayed by means of Guava Caspase 9 SR and Caspase 8 FAM
kit (EMD Millipore, Cat. No. 4500-0640), following manufac-
turer’s instructions. Cells were analyzed on flow microcapillary
cytometer. In acquired data cells were discriminated according
to expression of activated caspase-8, caspase-9, or both.
2.12. Assessment of changes in mitochondrial transmembrane
potential
Cells were treated over 6 h with investigated compound in con-
centration of 50 mM. After incubation was terminated, cells
were trypsinized and stained with FlowCellect MitoDamage
Kit (Merck Millipore Corporation, Darmstadt, Germany,
Cat. No. FCCH100106) according to manufacturer’s recom-
mendations. Analysis has been performed on flow microcapil-
lary cytometer. Cells were classified according to labeling with
Annexin V-FITC, MitoSense Red, and 7-AAD.
2.13. Determination of mitochondrial superoxide radical
generation
Cells were treated over 6 h with investigated compounds in
concentration of 50 mM, afterwards were stained with MitoSox
Red (Molecular Probes, Cat. No. M36008) according to man-
ufacturer’s recommendations. Analysis has been performed on
a flow microcapillary cytometer.
2.14. Growth inhibition of 3-D tumor models
3-D MCF-7 tumor models were made in 96 well plates (Corn-
ing, Sigma-Aldrich, St. Louis, Mo, USA, Cat No 4515).
Tumors were left to grow for additional four days, afterwards
investigated compound was added in concentrations of 1, 10,
and 100 mM. Evaluation has been maintained during 8-day
incubation period, with media exchanged on day 4. Changes
in the tumors sizes have been assessed on Celigo imaging
cytometer estimating the area of spheroids’ cross section (Cyn-
tellect, Brooks Life Science Systems, Poway, CA, USA) using
Celigo software. Growth rates of non-treated and treated
spheroids were computed for each day during 8-day incuba-
tion by dividing the area on the day n with the area on the
day 0.of the most studied thiosemicarbazone with pronounced pro-apoptotic activity,
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After 8-day incubation, non-treated and treated spheroids
were transferred to flat bottom 96 well plate (Corning
Costar, Cat. No. CLS3596), and segregated by trypsin in sev-
eral consecutive courses (BioWest, Nuaille, France, Cat No
L0930-100) with gently repeated pipetting. After spheroids
were completely dissociated into single cell suspensions, sam-
ples were treated according to recommendations of manufac-
turer with SmartFlare RNA probes (Millipore, Merck,
Darmstadt, Germany) or not (non-stained control): scrambled
control (negative control, Cat No SF-102), uptake control (Cat
No SF-114) and Oct-4 (Cat No SF-460). Incubation with
SmartFlare probes lasted for 16 h at 37 C in humidified atmo-
sphere containing 5% (v/v) CO2, afterwards all samples were
trypsinized and analyzed on a flow microcapillary cytometer.
2.16. DNA damage experiments
The ability of 3-AP and Se-3-AP to inhibit Cu(I)-driven plas-
mid DNA damage was assayed using a literature protocol
(Battin et al., 2011). Breafly, CuSO4 (6 lM), the indicated con-
centrations of 3-AP/Se-3-AP, EtOH (10 mM), deionized H2O,
3-(N-morpholino)propanesulfonic acid (10 mM), NaCl (130
mM), and ascorbic acid (1.25 equiv; 7.5 mM) were mixed at
pH 7 and allowed to stand for 5 min at room temperature.
Plasmid (pUC19, 0.1 pmol in 10 mM TrisHCl pH 8) was
added to each reaction mixture and the solutions were again
allowed to stand for additional 5 min. The hydroxyl radical
formation was initiated by the addition of H2O2 (50 mM).
After 30 min, EDTA (50 mM) was added to quench the
reactions.
2.17. Determination of metHb
Blood sample from healthy human donor was collected in
Vacutainer collection tubes (BD, Plymouth, UK) and used
immediately. RBC were isolated by centrifugation (480g for
5 min at 4 C) and then were washed in physiological solution.
To prepare RBC lysates, RBC were lysed with miliQ water, the
debris was removed by centrifugation (13000g for 30 min at 4
C), and the supernatant was used ([oxyHb] = 4.4 mM).
Working solutions of oxyHb (1.5 and 0.1 mM) were prepared
by dilution using 0.1 mM PBS (pH 7.4). Stock solutions of Se-
3-AP (5 mM) and 3-AP (5mM) were prepared by dissolving an
appropriate amount of substance in DMSO and further
diluted in 0.1 mM PBS (pH 7.4). The total content of DMSO
in tested samples was less than 0.5% (vol.%). Concentrations
of oxyHb and metHb were determined at 577 and 630 nm.
2.18. UV/vis and fluorescence spectroscopy
The working solutions of Se-3-AP different concentrations, as
indicated in the text, for UV/vis and fluorescence spectroscopy
were prepared by diluting the stock solution of Se-3-AP (5
mM) with 0.1 M PBS (pH 7.4) or DMSO. A stock solution
of Se-3-AP (5 mM) was prepared daily by dissolving an appro-
priate amount of substance in DMSO.Please cite this article in press as: Filipovic´, N.R. et al., Selenotriapine – An isostere
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Fatty acid free HSA (<0.007% fatty acids, Mw 66 478 Da)
was purchased from Sigma. A stock solution of HSA (0.25
mM) was prepared by dissolving an accurately weighed mass
of HSA in freshly prepared 0.1 M PBS (pH 7.4), and kept in
a freezer in 100 mL portions. A stock solution of Se-3-AP (5
mM) was prepared daily by dissolving an appropriate amount
of substance in DMSO. Millipore water was used for all aque-
ous solutions.
Binding of Se-3-AP to HSA was studied by fluorescence
quenching titration method using the intrinsic fluorescence of
HSA as probe. For fluorescence studies, solutions of HSA
and Se-3-AP were prepared daily by diluting the stock solu-
tions of HSA and Se-3-AP with 100 mM PBS pH 7.4 or
DMSO to the final concentrations of HSA (0.125 mΜ) and
Se-3-AP (80 mM), respectively. Before recording the fluores-
cence spectrum, diluted HSA solution was ultrafiltered using
filters with 0.45 lm pore size. Small aliquots of 80 lM Se-3-
AP solutions were added to 2.5 mL of 0.125 lMHSA solution.
The Se-3-AP was added in 1.5, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13,
14 and 15 M equivalents, so after the last equivalent, the total
DMSO did not exceed 2.4% in volume. After each aliquot
addition, the system was stirred and left to equilibrate for 5
min before fluorescence emission spectra were recorded in
the range 300–450 nm with an excitation wavelength of 280
nm and 0.1 s integration time. Spectra represent the average
of three accumulations and the background buffer signal was
subtracted from each spectrum. Fluorescence quenching data
were corrected for the inner-filter effect and further processed
(for details see Supplementary data).
2.20. Docking to HSA
Se-3-AP was optimized at B97D DFT level of theory
(Grimme, 2006), using LanL2DZ basis set for Se (Dunning
and Hay, 1977; Hay and Wadt, 1985), and 6-311G+(d,p) basis
set for C, N and H atoms (Krishnan et al., 1980; McLean and
Chandler, 1980). Geometrical optimization was carried in
Gaussian 09, revision D.01 (Frisch et al., 2016). Ligand was
afterwards prepared for docking in ADT Tools 1.5.6 (Morris
et al., 2009; Sanner, 1999). Three HSA crystal structures
(PDB IDs: 1BJ5 (Curry et al., 1998), 2BXD (Ghuman et al.,
2005), and 4L9Q (Wang et al., 2013) were obtained from the
Protein Data Bank (http://www.rcsb.org/pdb). The active sites
were identified according to positions of crystallized ligands in
the PDB structures. Ligands were removed, as well as water
and ions and structures were prepared for docking using Auto-
dock Tools 1.5.6 (Morris et al., 2009; Sanner, 1999). Docking
was carried in AutodockVina 1.1.2 (Trott and Olson, 2010).
The grid box size was set to 24  24  24 A˚ and exhaustiveness
to 250. All calculations were carried on PARADOX computer
cluster (Scientific Computing Laboratory of the Institute of
Physics, Belgrade, Serbia).
2.21. Artemia salina toxicity assay
A teaspoon of lyophilized eggs of the brine shrimp Artemia sal-
ina was added to a vessel filled with 1 L of the artificial seaof the most studied thiosemicarbazone with pronounced pro-apoptotic activity,
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dry yeast in 5 mL of distilled water). The vessel was partially
exposed to illumination and with assisted water aeration kept
for 48 h at 28 C. After hatching, nauplii were collected by pip-
ette at the illuminated side of the vessel. Tested compounds
were dissolved in DMSO (1 mg/100 mL) immediately before
the experiment. Five working concentrations have been made
with artificial seawater and added to vials which contained
10–20 hatched nauplii, thus the final concentrations of investi-
gated compounds were in the range 0.01–5 mg/mL. K2Cr2O7
in the same concentration range served as positive control.
Vials with nauplii, sea water and DMSO in concentrations that
corresponded to those in experimental samples (0.1–5%)
served as a negative control. All vials were left at 28 C, under
illumination, and water aeration for 24 h, afterwards live and
dead nauplii were counted. The LC50 concentration was deter-
mined as the one that induced death of 50% nauplii in treated
population. Each experimental sample has been performed in
duplicates.
2.22. Statistical analysis
Analyzed data were expressed in three replicates each obtained
from different experiments. The statistical significance of dif-
ferences was assessed using unpaired t test with Welch’s correc-
tion, or one-way ANOVA followed by unpaired t test with
Welch’s correction depending on number of groups to com-
pare, which is specifically notified in figure captions.
3. Results
3.1. Chemistry
The three step synthesis of Se-3-AP, with an overall yield of
66%, started from 3-amino-2-bromopyridine (Scheme 1).
The protection of amino group with ditert-butyl dicarbonate
(Boc2O) in dry THF was achieved using sodium bis-
(trimethylsilyl)amide as a base (Kowol et al., 2009). The tert-
Boc protected 3-amino-2-bromopyridine was than treated with
n-butyllithium (n-BuLi) in dry THF to obtain lithiated species,
which was further converted to carboxaldehyde by treatment
with N-formylpiperidine (Kowol et al., 2009). Condensation
reaction between ethanolic solutions of tert-Boc protected 3-
amino-2-formylpyridine carboxaldehyde and selenosemicar-
bazide in the presence of conc. HCl afforded Se-3-AP  HCl.
Hydrochloride salt was converted into Se-3-AP by treatment
with sodium bicarbonate. 3-AP was synthesized as previously
reported (Kowol et al., 2009).Scheme 1 Three step synthesis of Se-3-AP. Reagents and condit
(ii) n-BuLi, N-formylpiperidine; (iii) selenosemicarbazide, conc. HCl, N
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fluorescence and 1-D and 2-D NMR spectroscopy (Figs. S1–
S8, Supplementary data). In 1H NMR spectrum of Se-3-AP
in dimethylsulfoxide (DMSO)-d6 just one set of signals could
be observed, with the N-NH signal at 11.57 ppm. This indi-
cates, as previously observed for 3-AP and related 2-
formylpyridine thiosemicarbazones (Kowol et al., 2016;
Pessoa et al., 2001), that Se-3-AP exists in E-isomeric form.
In the UV/vis spectrum of Se-3-AP absorptions at 316 nm
(weak) and at 393 nm (strong) were found, while there is a
maximum at 457 nm in emission spectrum irradiated at kex
= 360 nm in DMSO. The redox behavior of Se-3-AP and 3-
AP has been investigated by cyclic voltammetry in the poten-
tial range from +1.2 to –2.0 V relative to Ag/AgCl reference
electrode. In the cyclic voltammogram of both Se-3-AP and
3-AP (Fig. S9, Supplementary data) there is one well defined
oxidation peak (Se-3-AP: +0.661 V; 3-AP: +0.628 V) and
one reduction peak (Se-3-AP: –0.857 V; 3-AP: –0.951 V).
The proton-dissociation processes of Se-3-AP were fol-
lowed by UV/vis spectrophotometric titration. Since Se-3-AP
is poorly soluble in water, 5% (v/v) DMSO/water solvent mix-
ture was found to be suitable media for aqueous solution equi-
librium study. UV/vis spectra of Se-3-AP in the pH ranges
1.73–6.49 and 6.49–11.88 are shown in Fig. 1. Two proton-
dissociation processes could be determined (Scheme 2) with
two well separated (DpKa > 3) pKavalues (pKa1 = 4.23 ±
0.01 at 404 nm and pKa2 = 9.75 ± 0.04 at 296 nm), as indi-
cated by clearly visible isosbestic points in the two pH regions.
Characteristic spectral changes of Se-3-AP can be observed in
the 250–450 nm wavelength range. Se-3-AP displays two
intense absorption bands due to n? p* transitions of the pyr-
idine ring and the selenosemicarbazide moiety (Filipovic et al.,
2016). During the first deprotonation step ([H2A]
+? [HA]), a
blue shift and a decrease in intensity of the absorption maxi-
mum in the visible region and a redshift and a decrease in
absorption maximum in the UV region of the spectra were
observed (Fig. 1A). The second deprotonation step ([HA]?
[A]–) was accompanied by a small redshift and slight decrease
in intensity of the absorption maximum in the visible region
and a decrease in absorption maximum without changes in
its position in the UV region of the spectra (Fig. 1B). As can
be seen from concentration distribution curves (Fig. 1C) the
neutral form of Se-3-AP predominates in the physiological
pH range. It should be noted that the determined constants
represent macro ionization constants. As shown in Scheme 1,
Ka1 represents the dissociation of the protonated pyridinium
unit, while Ka2coresponds to deprotonation of the hydrazone
nitrogen atom of the selenosemicarbazide moiety. Ka2 accountsions: (i) sodium bis(trimethylsilyl)amide (1 M, THF), (Boc)2O;
aHCO3.
of the most studied thiosemicarbazone with pronounced pro-apoptotic activity,
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Fig. 1 UV/Vis absorption spectra of Se-3-AP [c = 0.031 mM; t
= 25.0 C, I = 0.10 M (NaCl) in 5% (v/v) DMSO/H2O] recorded
in the pH ranges 1.736.49 (A) and 6.4911.88 (B). Spectra of pure
H2A+, HA and A– forms and isosbestic points are indicated. Se-
3-AP distribution diagram (C).
8 N.R. Filipovic´ et al.for different contributions of the selenone tautomer (shown in
Scheme 2) and selenenol tautomer (not shown).
The proton donating ability of Se-3-AP and 3-AP was
assayed using a protocol for the determination of radicalPlease cite this article in press as: Filipovic´, N.R. et al., Selenotriapine – An isostere
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method (Prior et al., 2005). IC50 values were calculated from
the plotted graph of scavenging activity against the concentra-
tions of the samples. IC50 is defined as the total antioxidant
necessary to decrease the initial DPPH radical concentration
by 50%. Vitamin C was used as the reference compound (pos-
itive control). The obtained IC50 values (in mM) are as follows:
1.13 ± 0.01, 3-AP; 0.107 ± 0.001, Se-3-AP; 0.079 ± 0.002,
vitamin C. These results showed that Se-3-AP is one order of
magnitude more potent antioxidant than 3-AP.
3.2. Anticancer activities
3-AP and Se-3-AP have been evaluated in terms of their ability
to induce cell apoptosis in THP-1 and MCF-7 malignant cell
lines. Compounds were added in a range of six concentrations
and left on cells for 24 h, afterwards percentages of live and
dead cells were determined by means of Annexin V/propidium
iodide (PI) dual staining assay. Both, 3-AP and Se-3-AP have
proven to be strong inducers of cell death in THP-1 cells but
with apparently different activity. Treatment of THP-1 cells
with 3-AP administered in a span from 1–100 mM predomi-
nantly induced accumulation of double stained events in the
quite high percentage already at the lowest employed concen-
tration, with a concentration-dependent increase throughout
the concentration range (Fig. 2A, left panel). At the same time,
percentages of Annexin V single-stained cells that represent
events in the early phase of apoptotic death, has remained at
the level of untreated control, while incidence of necrotic cells
remained above 10% and in almost all treated samples. Since
Annexin V/PI double stained cells can be interpreted as cells in
advanced phases of apoptosis or necrosis, the coincidental lack
of early apoptotic events clearly indicates that treatment with
3-AP induced a vigorous necrotic response in THP-1 cell line.
For that reason 3-AP is considered to possess an unfavorable
mode of activity and was not included in further evaluations
on this cell line. On the other hand, treatment of THP-1 cells
with Se-3-AP in initial range from 1–100 mM also induced a
major accumulation of double-stained cells, but those were
accompanied by significant percentages of cells at the initial
phase of apoptotic death (data not shown). Considering the
incidences of cell death were too high in the span of applied
concentrations describing only the top plateau of the concen-
tration–response sigmoidal curve so that ED50 concentration
could not be determined, it was necessary to decrease concen-
tration range of Se-3-AP on THP-1 cells half the way down to
0.5–30 mM. As represented in Fig. 2B, treatment with Se-3-AP
gradually and concentration-dependently increased percent-
ages of cells in early and late phases of apoptosis, whereas inci-
dence of necrosis was preserved on the level of untreated
control. Those data described sigmoidal concentration-
response curve with a wide slope while the top plateau begins
at the concentration of 30 mM (Fig. S10A, Supplementary
data). Such a curve is characteristic of a drug which dose
can be accurately titrated to achieve a desired outcome while
easily avoiding any toxic effect.
Treatment of MCF-7 cells with 3-AP (1–100 mM) resulted
in poor frequency of cell death while the majority of those
events were also in the process of necrotic death (Fig. 2A, right
panel). On the contrary, Se-3-AP on the same cell line induced
strong apoptotic response with concentration–response curve
nicely defined within applied range of 1–100 mM (Fig. 2Cof the most studied thiosemicarbazone with pronounced pro-apoptotic activity,
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Scheme 2 Proteolytic equilibria of Se-3-AP in aqueous media. HA, as neutral form of Se-3-AP, is represented in one tautomeric form,
while all tautomers coexist in solution.
Fig. 2 (A) Types of cell death in THP-1 (left panel) and MCF-7 cells (right panel) treated with 3-AP. Results are represented as
percentages of stained cells from a single experiment considering the replicates have not been acquired due to high toxicity or lack of
activity. (B) Types of cell death (left panel) and changes in cell cycle distribution (right panel) in THP-1 cells treated with Se-3-AP. (C)
Types of cell death (left panel) and changes in cell cycle distribution (right panel) in MCF-7 cells treated with Se-3-AP. Types of cell death
in each experiment were determined after 24 h incubation by Annexin V/PI double staining. Changes in cell cycle distribution on both cell
lines have been assessed on the same cell samples used for Annexin V/PI read out. Incidences of cells found in G0/G1, S and G2/M phases
were determined according to non-treated control population. Results in (B) and (C) are expressed as the mean ± SD (n = 2 independent
replicates).
Selenotriapine – An isostere of the most studied thiosemicarbazone 9and Fig. S10B Supplementary data). However, concentration–
response curve, which describes activity of Se-3-AP on MCF-7
cell line, distinguishes from that defined for THP-1 cells by thePlease cite this article in press as: Filipovic´, N.R. et al., Selenotriapine – An isostere
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the top plateau started already from the concentration of 50
mM (Fig. S10A, Supplementary data).of the most studied thiosemicarbazone with pronounced pro-apoptotic activity,
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sion in THP-1 cells caused by the treatment with Se-3-AP have
shown moderate concentration-dependent variations (Fig. 2B,
right panel). Moderate accumulation of dividing cells at the
G1-to-S phase of the cell cycle was evident up to the concentra-
tion of 3 mM, when a gradual decrease in percentage of cells at
the S phase was recorded. Thus in the samples treated with Se-
3-AP at 30 mM incidence of cells at the S phase returned to the
level of non-treated control accompanied with discrete accu-
mulation of cells at the G2/M phase. Gathering of cells at
the S phase was also found in the MCF-7 treated samples
(Fig. 2C, right panel). However, Se-3-AP at concentration of
1 mM aroused formation of S-to-G2 arrest that already at
the next concentration level of 10 mM shifted into cell collect-
ing at the G1-to-S phase. Considering necrosis was the domi-
nant form of cell death in THP-1 cells treated with 3-AP,
changes in cell cycle progression were not assessed due to their
irrelevance.
Although 3-AP showed weak pro-apoptotic activity in
MCF-7 cells, so that what type of changes it induced at 10,
50 and 100 mM only were evaluated (Fig. S11, Supplementary
data). Incubation of MCF-7 cells with 3-AP resulted in a slight
accumulation of cells at the G2/M phase instead at the G1-to-S
that was seen after treatment with Se-3-AP (Fig. 2B and C).
In order to evaluate the role of caspase activation in apop-
totic death of THP-1 and MCF-7 cells induced by the treat-
ment with Se-3-AP, cells were incubated with this compound
at the ED50 concentration with and without the presence of
the pan-caspase inhibitor N-benzyloxycarbonyl-Val-Ala-Asp(
O-Me) fluoromethyl ketone (Z-VAD-fmk). After 6 h of treat-
ment, cells were analyzed by means of Annexin V/PI dual
staining method, and changes in incidences of apoptotic and
necrotic events between samples treated with Se-3-AP alone
and co-incubated with Z-VAD-fmk were computed. As repre-
sented in Fig. 3A, the addition of pan-caspase inhibitor almost
completely inhibited apoptosis induced by Se-3-AP in both cell
lines. Nevertheless, the lack of caspase activity induced treated
cells to necrosis. This result demonstrates that apoptosis in
THP-1 and MCF-7 cells was highly dependent upon caspase
activation. The only dissimilarity observed between those
two cell lines concerns different caspase-dependency of apop-
totic death initiation, which may indicate on possibility that
Se-3-AP in MCF-7 cell also can trigger caspase-independent
apoptosis.
Further, we wanted to determine which caspase pathway
was primarily activated in THP-1 and MCF-7 cells by the
treatment with Se-3-AP. For that reason, cells were treated
with Se-3-AP at its ED50 concentration and assayed after 6 h
incubation for caspase-8 and -9 activities. Results are pre-
sented as average percentage of cells that express activated
either caspase-8 or caspase-9 alone, and an average percentage
of cells that express both activated caspases (Fig. 3B). In non-
treated THP-1 samples, a basic level of activated caspase-9
exits (5.9 ± 0.3% of cells), while percentages of cells with acti-
vated caspase-8 only or both caspases were very low (0.5 ±
0.4% and 0.4 ± 0.3%, respectively). Quite the opposite, per-
centage of non-treated MCF-7 cells with primarily activated
caspase-8 (3.3 ± 0.6%) and both activated caspases (3 ±
1%) dominated over activation of caspase-9 (0.6 ± 0.1%).
For Se-3-AP treated THP-1 samples high but non-
significant increase in percentage of cells positive for activated
caspase-9 only was found (20 ± 4%), whereas a high level ofPlease cite this article in press as: Filipovic´, N.R. et al., Selenotriapine – An isostere
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activated form of both caspases. Results of this assay definitely
reveal that the dominant mechanism of apoptosis triggered by
Se-3-AP in THP-1 cells involves activation of intrinsic apop-
totic pathway, whereas activation of caspase-8 arises as a result
of cross-talk between these two apoptotic pathways. Activa-
tion of caspase-9 was the mainstream event in MCF-7 cells
too. However, here the cross-talk between intrinsic and extrin-
sic apoptotic pathways evidently did not play any important
role in signal transduction during apoptotic process.
Capacity of Se-3-AP to induce generation of mitochondrial
superoxide radicals (O2
–) has been evaluated on both cell lines.
Percentages of THP-1 and MCF-7 cells positive for mitochon-
drial O2
– have been evaluated by MitoSox Red in cells after 6 h
incubation with Se-3-AP [50 mM]. Results were analyzed with
regard to following parameters: percentage of O2
–-positive
cells, and median fluorescence intensity (MFI) determined
for O2
–-positive subpopulation of cells expressed in arbitrary
units (AU). MFI is relevant of the quantity of generated O2
–
per cell. Percentages of O2
–-positive cells in non-treated con-
trols, THP-1 and MCF-7 cell lines are different in their basal
potential for generating mitochondrial O2
– (5.2 ± 0.7 AU
and 20 ± 7 AU for THP-1 and MCF-7 cells, respectively),
while MFI values for those controls were almost the same
(Fig. 4A and B). After addition of Se-3-AP to THP-1 cells, per-
centage of O2
– positive cells increased three fold, but the med-
ian amount of generated O2
– per cell remained at the level of
non-treated control. On the contrary, treatment of MCF-7
cells with Se-3-AP doubled the percentage of O2
–-generating
cells, whereas the amplitude of superoxide production per cell
was significantly higher than in control population. This result
demonstrates the phenotype-specific response to Se-3-AP
regarding mitochondrialO2
– generation.
Following the insight that treatment with Se-3-AP signifi-
cantly increased mitochondrial O2
– production in MCF-7 cells
only, together with the fact that activation of intrinsic apop-
totic pathway was the executive in the process of their apop-
totic death, it was decided to evaluate the loss of
mitochondrial transmembrane potential (MTP) in this cell line.
Evaluation of MTP dissipation has been assessed after 6 h
incubation of MCF-7 cells with Se-3-AP (c = 50 mM). Chosen
concentration being the same as for determination of mito-
chondrial O2
– production, allowing an unbiased estimation
whether generation of O2
– was the main cause for activation
of intrinsic apoptotic pathway. As seen in Fig. 4C, almost all
the cells in non-treated controls with altered MTP were addi-
tionally single-stained with 7-AAD indicating necrotic death.
Compared to control, treatment with Se-3-AP induced about
a twofold increase in percentage of cells with dissipated
MTP, whereas regarding their staining with Annexin V and
7-AAD a similar distribution was recorded as in non-treated
control. Majority of Se-3-AP-treated cells that showed loss
of MTP were 7-AAD single-stained, while only few of them
were labeled with Annexin V alone. Considering the short
incubation time and significantly small percentage of cells
found in early apoptosis (Annexin V-single stained events),
necrosis remains the main way leading to cell death.
The treatment impact on MCF-7 3-D spheroids was moni-
tored in regard of changes in size and morphology. Insufficient
mass transport of oxygen, nutrients and metabolites through
cellular barriers of spheroidal structure clearly distinguishes
three concentric zones: necrotic core (dark sphere located inof the most studied thiosemicarbazone with pronounced pro-apoptotic activity,
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Fig. 3 (A) Impact of pan-caspase inhibitor Z-VAD-fmk on incidences of apoptotic and necrotic cell deaths in THP-1 and MCF-7 cells
treated with Se-3-AP applied at ED50 concentration. (B) Percentage of THP-1 and MCF-7 cells with activated caspase-8 or/and caspase-9
due to treatment with Se-3-AP applied at ED50 concentration. All results are presented as the mean ± SD (n = 3 independent replicates).
Selenotriapine – An isostere of the most studied thiosemicarbazone 11the center of 3-D culture consisting of dead cells), quiescent
zone (transparent dark gray rim that surrounds necrotic core,
consisting of living non-dividing cells) and the proliferating
zone (transparent border located on the outer edge). For
non-treated spheroids, sizes and mutual ratio of those zones
will alter over days of incubation. Thus, due to the expansion
in size, necrotic core will get bigger while quiescent zone will
thin and shoves towards the very edge of the sphere
(Fig. 5A). Increase in size of control spheroids was 2.3 ±
0.1-fold in 8 days (Fig. 5B). Activity on 3-D culture was eval-
uated for Se-3-AP applied in 3 concentrations (1, 10 and 100
mM). Treatment with 1 mM is not presented due to lack of
activity. Se-3-AP at 10 mM caused a delay in growth of
MCF-7 spheroids. Regression in size regarding volumes on
the day 0 has not been achieved, but those spheres were signif-
icantly smaller compared to non-treated controls (Fig. 5B).
Considering proportion of the 3 structural zones, there were
no major differences observed comparing non-treated and
spheres treated with 10 mM (Fig. 5A). On day 6, quiescent zone
almost completely merged with the necrotic core barely distin-
guished on high magnification microscopy (data not shown).Please cite this article in press as: Filipovic´, N.R. et al., Selenotriapine – An isostere
low toxicity and ability to challenge phenotype reprogramming of 3-D mammary a
10.1016/j.arabjc.2017.11.017Finally, proliferation zone was completely obliterated on day
8, forming a crispy shaped brim as an indication of accelerat-
ing cell death. When compared to 10 mM, treatment with Se-3-
AP at 100 mM restrained spheroidal growth efficiently (1.0 ±
0.2-fold versus 1.4 ± 0.2-fold computed on day 8 for spheres
treated with 100 and 10 mM, respectively). Morphological
changes of spheroids in this concentration-treated group were
far more striking (Fig. 5A). Starting from day 2, quiescent
zone was gradually getting darker, accompanied with progres-
sive contraction of proliferation zone. On day 4, the prolifera-
tion zone was barely detectible, while on the next day their
edges became shredded. It is interesting to note that necrotic
core was easy to distinguish, with the quiescent zone preserved
until the end of the treatment.
The SmartFlare technology used here allows us the detec-
tion of gene expression in living cells with opportunity for
single-cell profiling. In this study, expression levels of
octamer-binding transcription factor 4 (Oct-4) was monitored.
Oct-4, has been found reactivated in many cancers concomi-
tantly with a reversion of cell phenotype from a highly differ-
entiated state to a highly undifferentiated state, whichof the most studied thiosemicarbazone with pronounced pro-apoptotic activity,
denocarcinoma tumors. Arabian Journal of Chemistry (2017), https://doi.org/
Fig. 4 (A) Percentages of THP-1 and MCF-7 cells positive for mitochondrial O2
– after 6 h treatment with Se-3-AP [50 mM], as
determined by MitoSox Red. Results are presented as the mean ± SD (n = 3 independent replicates). (B) MFI of MitoSox Red-stained
cells giving a median quantity of produced O2
– per cell. Statistical significance has been determined by unpaired t test with Welch’s
correction (n = 3 independent experiments). (C) Changes of mitochondrial membrane potential in MCF-7 cells after 6 h treatment with
Se-3-AP [50 mM], as determined by MitoSense Red. Results are presented as the mean ± SD percentage of cells discriminated according
to labeling by MitoSense Red, Annexin V and 7-AAD (n = 2 independent replicates).
Fig. 5 (A) Changes in size and morphology of MCF-7 3-D cultures induced by Se-3-AP applied at concentrations of 10 and 100 mM
over the 8-day treatment. Images were acquired daily starting from the day 0 with Celigo imaging cytometer using Celigo software. Scale
bar: 200 mm. (B) Growth rates of MCF-7 3-D cultures, non-treated and treated with Se-3-AP applied at concentrations of 10 and 100 mM.
Results are expressed as the mean ± SD (n = 3 independent replicates). Statistical significance has been determined by means of
Kruskal-Wallis test followed by unpaired t test with Welch’s correction as posttest.
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Selenotriapine – An isostere of the most studied thiosemicarbazone 13contributes to cancer development and aggressivity. Knowing
the contribution of Oct-4 in development of resistance and
tumor recurrence after applied treatment, it is important to
monitor its expression so to follow the putative aggressivity
of the leftover cells after chemotherapy (Emhemmed et al.,
2017). Results of Oct-4 detection should be considered in
respect to few important remarks. Assessment of Oct-4 expres-
sion has been estimated in the living cells only, a population
gated on forward scatter versus side scatter dot plot. Size of
this subpopulation varied between from 10 to 20% of all
acquired cells in our samples. In terms of previously reviewed
results of morphological analysis of non-treated and treated
spheroids on day 8, it is obvious that such a low percent of
viable cells was due to a massive necrotic core found in control
samples, and from accelerated cell death induced by applied
treatments. In general, majority of vital cells within spheroids
are situated in quiescent zone, consisted of cells in state of dor-
mancy, and in the proliferating zone.
In non-treated spheroids, a high percentage of cells dis-
played active transcription of Oct-4 gene after 16 h of incuba-
tion with SmartFlare detection probe (Fig. 6). Treatment with
Se-3-AP induced a noteworthy down-regulation of Oct-4
expressing cells in concentration-dependent manner
(Fig. 6A). While 10 mM Se-3-AP abolished Oct-4-
transcription in almost 50% of cells, treatment with 100 mMFig. 6 (A) Histogram of population of cells positive for RNA transcr
treatment with Se-3-AP applied at 10 and 100 mM (green), and non-tre
was determined by SmartFlareRNA detection probe. Results are ex
(B) MFI (AU) of Oct-4 expression indicating on median quantity of O
± SD (n = 3 independent 3-D replicates). Statistical significance has
Welch’s correction as posttest.
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MFI values, significant decrease in median Oct-4 mRNA tran-
scripts per cell was achieved only in spheroids subjected to Se-
3-AP at 100 mM (Fig. 6B). Those results reveal that treatment
with 100 mM Se-3-AP stimulates a strong phenotype repro-
gramming of MCF-7 cells.
3.3. Inhibition of Cu-mediated DNA damage
In order to compare ability of Se-3-AP and 3-AP in inhibition
of Cu(I)-mediated oxidative DNA damage, the assay devel-
oped by Battin et al. (2011) was employed. As it can be seen
in Fig. 7, both Se-3-AP and 3-AP showed the ability to miti-
gate oxidative DNA damage caused by hydroxyl radical gener-
ated in the Fenton reaction. Agarose gel electrophoresis of
pUC19 DNA plasmid alone revealed that almost all DNA
was in a supercoiled form (SC), with nicked form (NC) only
in traces, while linear form (L) was not evident (Fig. 7, lanes
1). Hydrogen peroxide alone (Fig. 7, lanes 2) and in a combi-
nation with 3-AP and Se-3-AP (Fig. 7A lane 3 and Fig. 7B lane
3, respectively) did not induce any damage on plasmid DNA,
since proportion of SC and NC forms remained unchanged in
respect to native plasmid DNA. However, when plasmid DNA
was incubated with Cu(I) and H2O2 (reactive mixture), the SCipts of Oct-4 mRNA in MCF-7 3-D cell cultures afterwards 8-day
ated controls from the same experiment (red). RNA transcription
pressed as the mean ± SD (n = 3 independent 3-D replicates).
ct-4 RNA transcripts per cell. Results are expressed as the mean
been determined by Kruskal-Wallis test, with unpaired t test with
of the most studied thiosemicarbazone with pronounced pro-apoptotic activity,
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Fig. 7 Agarose gel showing a reduction in oxidative DNA
damage with increasing concentration of 3-AP (A) and Se-3-AP
(B). Lanes: (MW) GeneRuler DNA 0.1–10.0 kb ladder mix; (1)
plasmid DNA; (2) DNA+H2O2; (3) DNA+ 3-AP/Se-3-AP +
H2O2; (4) DNA+ Cu(II)/ascorbate + H2O2; (5–11) same as lane
4 with increasing concentration of 3-AP/Se-3-AP: 0.1, 1, 5, 10, 50,
100 and 1000 mM, respectively.
Fig. 8 MetHb formation induced by 3-AP and Se-3-AP. (A)
RBC lysates [total Hb concentration 0.1 mM in 0.1 mM phos-
phate buffer saline (PBS) pH 7.4] was incubated without (control)
and with Se-3-AP or 3-AP (10, 5 and 1 lM). (B) RBC lysates (total
Hb concentrations of 1.5 and 0.1 mM in 0.1 mM PBS pH 7.4)
were incubated without (control) and with sixty times lower
concentration of Se-3-AP or 3-AP (25 lM or 1.67 lM, respec-
tively). Maximum incubation period was 1320 min at 37 C.
Results are means ± S.D. for three experiments.
14 N.R. Filipovic´ et al.form completely disappeared, while NC became dominant
with L form found in traces (Fig. 7, lanes 4). As it can be seen
in Fig. 7 (lanes 5–11), when 3-AP or Se-3-AP were added to the
reactive mixture, concentration-dependent shifts in ratio of
plasmid DNA forms were achieved.
3.4. In vitro metHb formation
To assess the effect of Se-3-AP on in vitro metHb formation
compared to 3-AP, a solution of Hb (0.1 mM), obtained from
red blood cells (RBC) lysate of healthy human donor, was
incubated without (control) and with Se-3-AP and 3-AP (10,
5 and 1 mM) for up to 22 h at 37 C. The content of metHb
in the incubation mixtures was determined by the standard
method (Winterbourn and Carrell, 1977). The results are
shown in Fig. 8A. MetHb fraction in non-treated controls at
0 min was 2.4%, which is in the range for metHb values deter-
mined in healthy individuals (0–3%) (He and Carter, 1992).
Results showed that metHb concentration increased time-
and dose-dependently in the samples treated with Se-3-AP
and 3-AP (Fig. 8A). 3-AP at concentrations 10 and 5 lM
induced statistically significant (p < .05) increase of metHb
content compared to the control after 60 and 240 min of incu-
bation, respectively. After 22 h of incubation 10 lM concen-
tration of 3-AP induced about three times higher metHb
content, compared to the control. In the samples treated with
Se-3-AP (5 and 10 mM), statistically significant increase inPlease cite this article in press as: Filipovic´, N.R. et al., Selenotriapine – An isostere
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of incubation. Also, Se-3-AP and 3-AP (1 lM) prevented
metHb formation over the first 240 min of incubation period,
while only 3-AP (1 lM) after 22 h led to significantly (p <
.05) increased metHb formation, compared to the control.
Since oxyHb concentration in the blood of healthy individ-
uals is 15–25 times higher than its concentration in this exper-
iment, to assess the metHb formation in circumstances that are
more physiological, 1.5 mM of oxyHb was incubated without
(control) and with Se-3-AP and 3-AP (25 mM) for up to 22 h
at 37 C. Results of this experiment were compared to those
when 0.1 mM oxyHb was incubated without (control) and
with Se-3-AP and 3-AP (1.67 mM), thus in both settings molar
ratio of oxyHb: Se-3-AP/3-AP was 60: 1 (Fig. 8B). With ele-
vated Hb concentration in the incubation mixture, effects of
Se-3-AP and 3-AP were more pronounced and an increase ofof the most studied thiosemicarbazone with pronounced pro-apoptotic activity,
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Fig. 9 (A) Changes in UV/vis absorption spectra of Se-3-AP (64
mM in 100 mM PBS pH 7.4) upon addition of HSA in the
following molar ratios Se-3-AP/HSA: (a) 1:0.06; (b) 1:0.07; (c)
1:0.08; (d) 1:0.1; (e) 1:0.125; (f) 1:0.17; (g) 1:0.25; (h) 1:0.5. UV/vis
absorption spectrum of HSA (4 mM) is represented with a dashed
line. (B) Changes in fluorescence emission spectra of HSA (0.125
mM in 100 mM PBS pH 7.4) upon addition of Se-3-AP in the
following molar ratios HSA/Se-3-AP: (a) 1:0; (b) 1:1.5; (c) 1:3; (d)
1:4; (e) 1:5; (f) 1:6; (g) 1:7; (h) 1:8; (i) 1:9; (j) 1:10; (k) 1:11; (l) 1:12;
(m) 1:13; (n) 1:14; (o) 1:15.
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concentrations of 3-AP (25 and 1.67 lM) led to statistically
significant (p < .05) rise in metHb content compared to corre-
sponding controls after 120 min, while Se-3-AP (25 lM)
achieved significantly higher genesis of metHb only after 22 h
of incubation compared to the corresponding control (6.7 ±
0.1% and 3.8 ± 0.5%, respectively). After 22 h of incubation,
for all concentrations of Se-3-AP and all molar ratios of
oxyHb: Se-3-AP, the obtained metHb content was always
below 8.5% (Fig. 8).
3.5. Interaction with HSA
UV/vis and fluorescence spectroscopy were used to study inter-
action of Se-3-AP with HSA. UV/vis spectra of Se-3-AP with
increasing amounts of HSA (Se-3-AP/HSA molar ratios from
1: 0.06 to 1: 0.5) showed a blue kmax shift (from 373 to 367 nm,
Fig. 9A). Interaction between HSA and Se-3-AP lead to
changes in the absorption spectra of Se-3-AP upon its binding
to HSA. The changes in fluorescence emission spectra of HSA
with increasing amount of Se-3-AP (Se-3-AP/HSA molar
ratios from 1.5: 1 to 15: 1) are shown in Fig. 9B. The excitation
wavelength was 280 nm, at which both Trp214 and Tyr resi-
dues emit fluorescence. In spite of the presence of 18 Tyr resi-
dues in HSA molecule (He and Carter, 1992), the HSA
intrinsic fluorescence is dominated by single Trp214 in subdo-
main IIA (Lakovicz, 2006). The binding of Se-3-AP to HSA
resulted in fluorescence quenching at kem (340 nm). In the pres-
ence of Se-3-AP, the intrinsic fluorescence decreased in a
concentration-dependent manner, suggesting that Se-3-AP
interact with HSA. A blue shift in the emission maximum
wavelength occurred, indicating that the microenvironment
around Trp214 is altered into a more hydrophobic as the
HSA–Se-3-AP adduct is formed (Li and Yang, 2015).
Fluorescence quenching data were further processed in
order to perform more detailed characterization of Se-3-AP–
HSA binding. The obtained Stern–Volmer quenching constant
(Ksv), the quenching rate constant (kq), the effective quenching
constant for the accessible fluorophores (Ka), the fraction of
accessible fluorophore (fa), thermodynamic binding parame-
ters, association constants (Kb) and number of binding sites
(n) of HSA are given in Table 1 and Figs. S12–S15 (Supple-
mentary data). Obtained values for Ksv decrease as tempera-
ture increases. The values for Ksv indicate that the quenching
mechanism is static. The obtained kq values are three orders
of magnitude higher than the limiting diffusion rate constant
of the biomolecule (1010 M1 s1), indicating a static type
mechanism of fluorophore quenching (Li et al., 2014). The
Ka is inversely correlated with temperature, which is in accor-
dance with Ksv temperature dependency. The obtained values
for DH and DS are –5.70 kJ mol–1 and 88.56 kJ mol–1, respec-
tively. At all three temperatures obtained values for n were
close to 1.
To further examine the binding of Se-3-AP to HSA, the
docking in ibuprofen binding site of HSA was performed.
Molecular docking gave conformations with the lowest bind-
ing energy of –5.5 kcal mol–1, i.e. 92 mM. There is an aromatic
interaction formed between Trp214 and aromatic ring of Se-3-
AP. Selenium atom also forms Se  p interactions with the
same amino acid residue. Hydrogen bonds with Ser464 and
Glu450 are formed via selenoamide group (Fig. 10).Please cite this article in press as: Filipovic´, N.R. et al., Selenotriapine – An isostere
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Acute toxicity of 3-AP and Se-3-AP was tested on brine shrimp
Artemia salina after 24 h incubation and results are expressed
as LC50 values. DMSO, as negative control, did not cause
changes in viability of treated nauplii. Treatment with
K2Cr2O7, as positive control, induced high incidence of lethal-
ity (LC50 = 248.14 ± 16.85 lM). Nauplii revealed different
level of sensitivity toward 3-AP and Se-3-AP, where LC50 val-
ues are 563.41 ± 21.35 and 867.27 ± 19.78 lM, respectively.
While LC50 for 3-AP was found to be only 1.5-fold higher
compared to LC50 of K2Cr2O7, the concentration of Se-3-AP
has to be three times as that of K2Cr2O7 to achieve the death
in a half of treated nauplii.of the most studied thiosemicarbazone with pronounced pro-apoptotic activity,
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Table 1 The Stern–Volmer quenching constant (Ksv), the quenching rate constant (kq), the effective quenching constant for the
accessible fluorophores (Ka), the fraction of accessible fluorophore (fa), the change in the Gibbs free energy (DG), association constants
(Kb) and number of binding sites (n) of HSA at three temperatures. Results of binding of Se-3-AP to HSA obtained using the modified
Stern-Volmer plot; thermodynamic parameters of binding are calculated using the Van’t Hoff equation.
T (K) Ksv  105 (M1) kq  1013 (M1 s1) Ka  105 (M1) fa DG (kJ mol–1) Kb  105 (M1) n
293 4.27 ± 0.10 6.02 4.31 ± 0.02 0.893 31.65 4.44 ± 0.15 1.049
298 4.08 ± 0.06 5.75 4.19 ± 0.04 0.862 32.09 4.15 ± 0.07 1.044
310 3.87 ± 0.03 5.46 4.03 ± 0.08 0.833 33.15 3.88 ± 0.13 1.048
16 N.R. Filipovic´ et al.4. Discussion
Spectroscopic and electrochemical data point out to similari-
ties rather than differences among Se-3-AP and 3-AP. UV/
vis spectra of both Se-3-AP and 3-AP showed two absorptions
in the region 260–450 nm. These maximums are attributed to
n? p* transitions of the pyridine ring and chalcogensemicar-
bazide moiety (Enyedy et al., 2010; Filipovic et al., 2016). Se-3-
AP in DMSO solution irradiated at kex = 360 nm exhibits
maximum at 457 nm in emission spectrum, which is identical
to 3-AP (Kowol et al., 2010). 1H and 13C NMR spectral data
indicate very small changes in corresponding chemical shifts of
Se-3-AP in comparison to 3-AP (Niu et al., 1998). This is in
accord with previously published comparative studies for
structurally related selenosemicarbazones and thiosemicar-
bazones where isosteric replacement of sulfur with selenium
did not have strong influence on spectroscopic features of
two classes of compounds (Castle et al., 2003; Kowol et al.,
2008; Todorovic et al., 2017). The chemical shift of 77Se
(Fig. S8) was found at a little higher field in comparison to
related 2-formylpyridine selenosemicarbazone (Todorovic
et al., 2009). All observed peaks in cyclic voltammograms of
Se-3-AP and 3-AP are attributed to the irreversible electro-
chemical reactions. Values obtained for reduction peaks are
similar to values obtained for pyridine based chalcogensemi-
carbazones containing methyl substituents, but with opposite
trends (Kowol et al., 2008). Se-3-AP is slightly weaker acid
in the first and stronger acid regarding second dissociation step
comparing to 3-AP (Enyedy et al., 2010). Similarly to 3-AP,
the neutral form of Se-3-AP predominates in the physiological
pH range.
Because selenium and sulfur antioxidants can alleviate
oxidative damage, numerous animal and clinical trials have
investigated the ability of these compounds to prevent the
oxidative stress that is an underlying cause of cancer. Selone
(C = Se) and thione (C = S) compounds were recognized as
potent antioxidants (Zimmerman et al., 2015). Our previous
study of quinoline based non-substituted selenosemicar-
bazones showed that they had an excellent free radical-
scavenging effect, which was greater than that of reference
antioxidant vitamin C (Filipovic et al., 2014, 2015). One recent
comparative study of free radical scavenging activity of disub-
stituted seleno- and thiosemicarbazones also confirmed a great
free-radical scavenging potential of these classes of com-
pounds, but general conclusion about impact of nature of
chalcogen atom on antioxidant activity could not be estab-
lished (Calcatierra et al., 2015). IC50 value obtained for Se-3-
AP indicates that it is one order of magnitude more potentPlease cite this article in press as: Filipovic´, N.R. et al., Selenotriapine – An isostere
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min C.
It was previously demonstrated that rapidly dividing neo-
plastic cells require the excessive amount of iron, which is
the reason for them to express markedly elevated level of trans-
ferrin receptors thus facilitating enhanced iron uptake
(Hogemann-Savellano et al., 2003; Walker and Day, 1986).
Those evidences have raised the attention toward chelating
agents that became attractive as a potentially useful treatment
against cancer growth. Evaluation of thiosemicarbazones that
act as chelating agents revealed cancer cells tend to be more
susceptible to their activity compared to normal cells
(Kalinowski and Richardson, 2005; Whitnall et al., 2006). 3-
AP reduced growth of a panel of 60 cell lines for 50% (IC50)
in an average concentration of 1.6 mM (Finch et al., 2000;
Knox et al., 2007). In another study, 3-AP achieved IC50 con-
centration of 0.45 mM against human ovarian cystadenocarci-
noma cells (41 M) and 0.52 mM on human mammary
adenocarcinoma cell line (SK-BR-3) (Enyedy et al., 2011).
Furthermore, 3-AP showed high activity against growth of
M109 murine lung carcinoma, A2780 human ovarian carci-
noma xenograft, hydroxyurea (HU) resistant L1210 leukemia
and HU-resistant KB nasopharyngeal carcinoma in vivo mod-
els (Cory et al., 1994; Finch et al., 2000). Having ability to
cross blood/brain barrier, 3-AP effectively eliminated more
than 95% leukemia cells in the brain, which is result compara-
ble to that previously reported for cyclophosphamide (Avery
et al., 1990).
Results of clinical trials removed the focus from 3-AP as
potentially single effective agent to its role in combination
treatments. The best anticancer activity in men 3-AP achieved
in combination with fludarabine for the treatment of refrac-
tory myeloid malignancies, where this combination demon-
strated complete response in 17% patients compared with no
response in groups treated with 3-AP or fludarabine alone
(Karp et al., 2008). In our study, 3-AP was tested on two
heterogeneous cell lines but revealed high activity only against
THP-1 leukemia cell line. Here necrosis was a prevailing mode
of cell death that is in agreement with its clinically established
unfavorable toxicity profile. Quite contrary, current results
show that Se-3-AP is a powerful inducer of apoptotic cell
death in THP-1 and MCF-7 cell lines, while results of intracel-
lular events and toxicity profiles strongly indicate that 3-AP
and Se-3-AP do not share the same mechanism of activity.
The main mechanism of 3-AP activity was defined to be
inhibition of RR, an enzyme that supplies monomeric precur-
sors required for DNA replication and repair (Nordlund and
Reichard, 2006). In the paper, published by Barker et al.of the most studied thiosemicarbazone with pronounced pro-apoptotic activity,
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Fig. 10 Se-3-AP docked into ibuprofen binding site of HSA. Green: hydrogen bonds, pink: aromatic interactions; yellow: Se  p
interactions.
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after 16 h treatment with 3-AP in U251 cells (human glioma),
DU145 cells (prostate carcinoma) and PSN1 cells (pancreatic
carcinoma). In all three cell lines significant accumulation of
cell at the G0/G1 phase was seen, accompanied with decreased
percentage of S and G2/M phases (Barker et al., 2006). In our
study, treatment of MCF-7 cells with 3-AP resulted in a slight
accumulation at the G2/M phase instead of the expected G0/
G1 block. Current results of cell cycle distribution should be
considered in relation with 3-AP poor pro-apoptotic activity
revealed in that particular cell line.
Cell cycle changes recorded for Se-3-AP-treated cells in the
present study have led to the following conclusions. First, Se-
3-AP induced various perturbations within phases of mitotic
division amongst treated cell lines, meaning that this com-
pound affected each cell line in a phenotype-specific manner.
Thus, while Se-3-AP stimulated moderate accumulation at
the S phase in most of THP-1 and MCF-7 samples, concentra-
tion that achieved the highest incidence of apoptosis on THP-1
cells did not cause any change within cell cycle distribution,
while S-to-G2 block, found for MCF-7 cells, was never seen
for THP-1 cells. Second, in both cell lines treatment with Se-
3-AP resulted in cell cycle perturbations that altered
concentration-dependently. This was most prominent in
MCF-7 cells, where Se-3-AP at 1 mM triggered S-to-G2 block,
while at the same time did not cause significant percentage of
cell death. Increase of Se-3-AP concentration up to 30 mM
gradually moved the magnitude toward G1-to-S checkpoint
in coincidence with the massive apoptotic response. Such
results can be addressed to a concentration-dependent mecha-
nism of activity, which Se-3-AP might performs also indepen-
dently of cell line phenotype.
It was proposed that redox active Fe(III)/(II)-3-AP com-
plex plays a role in cytotoxicity, with ROS being suggested
as ultimately responsible for pharmacologic effects of 3-AP
(Shao et al., 2006). However, Aye et al. (2012) revealed that
RR is inhibited by Fe(II)-3-AP without ROS formation. Their
results were confirmed by other group that demonstrated 3-AP
caused pronounced oxidation of mitochondrial thioredoxin-2
and its dependent peroxidase peroredoxin-3 in human cells
without effect on cytosolic thioredoxin-1 (Myers et al., 2011).
Therefore, the redox stress induced by 3-AP treatment is lar-Please cite this article in press as: Filipovic´, N.R. et al., Selenotriapine – An isostere
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on 3-AP activity, we tested capability of Se-3-AP to induce
mitochondrial O2
– production in THP-1 and MCF-7 cell lines.
While in non-treated THP-1 samples percentage of O2
–-
positive cells was low, the incidence of O2
– in MCF-7 control
samples has been several times higher. There is an interesting
positive correlation found between MCF-7 non-treated sam-
ples in two different assays, both regarding mitochondrial
equilibrium. Precisely, percentage of non-treated MCF-7 cells
positive for O2
– production was almost equal to percentage
of non-treated cells positive for dissipated MTP. Comparison
of O2
–-positive events between THP-1 and MCF-7 cells in
respect to matching controls reveals that treatment with Se-
3-AP gained tripled increase in THP-1 cells and doubled
increase in MCF-7 cells. However, values of MFI computed
for O2
–-positive subpopulation of cells demonstrated that O2
–
production in MCF-7 cells was significantly amplified on a cel-
lular level. Furthermore, strong correlation between results of
mitochondrial O2
– production and altered MTP in MCF-7
samples treated with Se-3-AP was confirmed as well.
Under physiological conditions mitochondrial O2
– are gen-
erated as a result of electron leakage from the respiratory chain
and their afterwards reaction with oxygen. Superoxide is fur-
ther converted to hydrogen peroxide by means of manganese
dependent superoxide dismutase (MnSOD) activity, also
known as SOD2 (Fukai and Ushio-Fukai, 2011). SOD2 is
strategically located to mitochondrial inner membrane, and
as a key mitochondrial antioxidant enzyme has a critical role
in protection of cell vitality from oxidative stress. Activity of
SOD2 is regulated by the deacetylase SIRT3, which expression
was recently found to be abolished in 87% of breast cancers
(Finley et al., 2011; Tao et al., 2010; Mohan et al., 2016).
Papa et al. (2014) showed that the expression of SOD2 is
reduced by 50–90% in a panel of breast cancer cell lines com-
pared to human breast epithelial cells (MCF-10A). Thus,
antioxidant status in breast cancer cells was maintained owing
to mitochondrial fraction of Cu/ZnSOD (SOD1) (Fukai and
Ushio-Fukai, 2011). Additionally, MCF-7 cells were shown
to have lower expression of mitochondrial SOD1 compared
to MDA-MB-231 human breast cancer cell line (Papa et al.,
2014). Moreover, recent study revealed that compared to
MCF-10A cells, MCF-7 cell line has significantly higherof the most studied thiosemicarbazone with pronounced pro-apoptotic activity,
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ration (Andrzejewski et al., 2014). The mitochondrial respira-
tory chain uncoupling is the phenomenon that allows the
return of proton into the matrix without ATP production.
The proton leak lowers potential across the mitochondrial
inner membrane, increasing the mitochondrial respiration rate
and O2
– production (Fontanesi, 2015). All these facts are lead-
ing to the following conclusions. First, high mitochondrial O2
–
production found in MCF-7 cells after Se-3-AP treatment
might relies on distinctive characteristic of the particular cell
line, but not on the property of the tested compound. Second,
THP-1 cell line was not reported for impaired mitochondrial
antioxidant status, thus significantly lower MFI in those cells
compared to MCF-7 cell line might resulted from fast and effi-
cient neutralization of superoxide radicals. Those claims are
additionally supported by distribution of cells in MitoSOX
Red histograms which showed that all THP-1 cells were more
or less affected, whereas MCF-7 cells were markedly divided in
two subpopulations where the one was strikingly negative for
O2
– whereas the other was highly positive.
Previously published reports indicate that cell death
induced by 3-AP was primarily related to activation of
caspase-8 induced by ER stress, probably due to formation
of ROS, with secondary activated caspase-9 (Alvero et al.,
2006; Jimbo et al., 2003). Our results revealed that apoptosis
triggered by Se-3-AP in THP-1 cells is highly caspase-
dependent and conducted by activation of caspase-9 with sec-
ondary activated caspase-8. Katoh et al. (2004) demonstrated
that mitochondrial O2
– can launch caspase-9 activation, which
was revealed as the dominant course of apoptosis initiation in
both cell lines we have treated in our study. However, compar-
ing intensity of apoptotic induction in THP-1 cells and per-
centage of O2
– positive cells, strongly suggests that activation
of the intrinsic apoptotic pathway may be rather related to a
different incentives.
The inner mitochondrial membrane is the established fron-
tier between mitochondrial inter-membrane space and mito-
chondrial matrix. It is nearly impermeable to all ions, which
in turn allows respiratory chain to build up a proton gradient
that is required for oxidative phosphorylation (Mitchell and
Moyle, 1965a; Mitchell and Moyle, 1965b). Such electrochem-
ical gradient across the inner membrane forms the basis of the
MTP that is of vital importance for cellular bioenergetics
(Kroemer et al., 2007). Dissipation of MTP drives a series of
consequences that eventually lead to cell death including
immediate arrest of mitochondrial ATP synthesis, mitochon-
drial swelling, an increase of outer mitochondrial membrane
permeability with translocation of numerous proteins from
mitochondrial inter-membrane space to cytosol that activate
the caspase cascade as well as caspase-independent cell death
mechanisms (Galluzzi et al., 2008; Galluzzi et al., 2010). In
our study, a vast majority of non-treated MCF-7 cells with
altered MTP ended in necrosis, whereas the treatment with
Se-3-AP raised the percentage of cells with dissipated MTP
but did not change the course in type of cell death. Addition-
ally, we found a tight correlation between O2
– generation and
MTP dissipation: percentage of cells positive for O2
– produc-
tion was almost equal to percentage of cells with altered
MTP, both in non-treated and Se-3-AP-treated samples. With
a look back, to clearly segregated subpopulations of O2
–-
positive and -negative MCF-7 cells that was discussed above,
together with the fact MCF-7 cell line does not represent a sin-Please cite this article in press as: Filipovic´, N.R. et al., Selenotriapine – An isostere
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(Comsa et al., 2015), it becomes obvious that Se-3-AP affected
MCF-7 cells by a dual mechanisms. The early event is O2
–-
dependent and targets susceptible subpopulation of cells driv-
ing them into necrotic death. The late event implies triggering
of apoptosis as validated at 24 h assessments. The reason O2
–
production and dissipation of MTP did not lead to apoptosis,
as well as the mechanism responsible for caspase-9 activation
by Se-3-AP treatment of MCF-7 cells remains to be elucidated
in further investigations.
After highly promising preclinical data on 3-AP activity,
clinical research discovered disappointing results using 3-AP
either as a single agent or in combination treatment against
solid tumors (Yu et al., 2006). Considering that our study is
the first evaluation of Se-3-AP activity where not all aspects
of its activity could be investigated, we wanted to assess the
effect of Se-3-AP treatment on in vitro derived 3-D tumor
model. Spheroid 3-D culture is the unique in vitro tumor
model which architecture well mimics in vivo tumor mass with
the exception of vasculature and immune system (Grimes
et al., 2014). Thus, 3-D models serve as a unique screening
platform for drug effectiveness in a function of multiple
parameters such as gradient of nutrients, oxygen and metabo-
lites within themselves (Lin and Chang, 2008). Both applied
concentrations of Se-3-AP achieved statistically significant
delay in growth of MCF-7 spheres compared to control,
although none of them induced regression in size of spheroids
compared to the first day of evaluation.
SmartFlare technology that was used in our study allows
detection of gene expression in living cells with the possibility
of single-cell profiling. Since added oligonucleotide probes do
not harm cellular integrity and vitality, it is possible to trace
changes in gene expression levels due to applied treatment
for several targets at the same time (Lahm et al., 2015). Partic-
ularly important is that single-cell expression profiling pro-
vides information that cannot be deduced from population
measurements (Stahlberg et al., 2013; Stahlberg and Kubista,
2014). Oct-4 has been shown as essential for maintaining
undifferentiated and pluripotent populations of cells. Its
expression profile has been found highly correlated with tumor
grade and disease progression (Karoubi et al., 2009; Zhang
et al., 2010). Ectopic Oct-4 expression was shown to enhance
the features of cancer stem cells in a murine model of breast
cancer (Kim and Nam, 2011). Besides that it has important
role during tumorigenesis, its stake in development and preser-
vation of drug-resistant phenotype was also confirmed (Wang
et al., 2010). Recent studies demonstrated a tight relation
between Oct-4 expression and the epithelial to mesenchymal
transition (EMT) process (Dai et al., 2013; Kong et al., 2010;
Syn et al., 2016). However, it was shown that suppression of
Oct-4 expression in MCF-7 cell line promoted invasion and
metastasis by induction of EMT (Hu et al., 2011). These con-
tradictory findings suggest that changes in Oct-4 expression
can either induce differentiation of cancer cells or to increase
their plasticity, meaning that the EMT process may be tightly
regulated by endogenous expression of Oct-4. Oct-4 expression
rises in residual breast cancer cells that survived the treatment,
while the level of its expression is in positive correlation with
unfavorable clinical outcome (Magnifico et al., 2009; Saigusa
et al., 2009; Zhang et al., 2010). Additionally, hypoxic condi-
tion was confirmed to have enhancing influence, with Oct-4
gene is a target of hypoxia inducible factor 2a (Covelloof the most studied thiosemicarbazone with pronounced pro-apoptotic activity,
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icant concentration-dependent down-regulation of Oct4
expression in treated 3-D cultures. Discussing in terms of mor-
phological features, Se-3-AP at 100 mM heavily affected prolif-
erative zone that was unrecognizable from the day 3 of
treatment while the quiescent zone was recognizable until the
end of the treatment. On the contrary, in spheres treated with
Se-3-AP at 10 mM, the proliferative rim could be seen on the
day 6 to finally disappear on the day 8, whereas quiescent zone
was visually merged with necrotic core from the day 6. These
facts indicate the possibility that living cells in spheres incu-
bated with 10 mM of Se-3-AP derive from quiescent zone
and are more affected by hypoxia. Therefore, it is possible that
challenged hypoxic conditions in 3-D cultures subjected to Se-
3-AP at 10 mM affects Oct-4 expression in correlation with
non-significant changes in MFI values of these spheroids com-
pared to non-treated controls, despite noteworthy decrease in
percentage of Oct-4-expresing cells. On the other hand, 100
mM Se-3-AP brought all the benefits, including superior con-
trol of 3-D tumor growth, threefold decrease in percentage
of Oct-4-expresing cells, as well as statistically significant
restriction in number of mRNA copies within the remaining
Oct-4 transcribing cells. It is obvious that cells that survived
treatment with Se-3-AP at 100 mM did not raise expression
of this gene as it was reported in other cases (Magnifico
et al., 2009; Saigusa et al., 2009; Zhang et al., 2010). Thus, this
result is the solid proof that Se-3-AP has the ability to induce
phenotype reprogramming of 3-D breast cancer tumors.
Cellular generation of OH, which typically occurs by metal
mediated H2O2 reduction, is the major cause of DNA damage
in human cells (Bar-Or et al., 2001; Battin et al., 2011). This is
linked to development of cancer (Zimmerman et al., 2015).
Here we used the assay for determination of inhibition of Cu
(I)-mediated oxidative DNA damage to compare activities of
Se-3-AP and 3-AP (Battin et al., 2011). Complete neutraliza-
tion of free reactive species and protection of plasmid SC form
has been accomplished with 3-AP in concentration of 50 mM,
whereas starting from the next concentration level (100 mM)
nuclease activity became evident which emerged as a result
of 3-AP complexation with Cu from the reactive mixture.
The addition of Se-3-AP also resulted in concentration-
dependently decrease in quantity of generated NC form, but
its disappearance was attained when Se-3-AP was added to
reaction mixture in concentration of 100 mM which coincided
with creation of Cu complex and pUC19 DNA degradation.
Our results showed that in DPPH test, Se-3-AP appear to be
more potent antioxidant than 3-AP. It was not possible to
establish correlation between free radical-scavenging activity
and protection abilities of compounds, since 3-AP protected
DNA at lower concentrations in comparison to Se-3-AP.
The side effects of anticancer agents are the most common
causes that may limit their clinical use. During the pre-clinical
and clinical studies, it was found that 3-AP increases the oxi-
dation of Hb to metHb, which cannot transport oxygen caus-
ing methemoglobinemia, hypoxia and cyanosis (Kunos et al.,
2010; Kunos et al., 2012; Ma et al., 2008; Stefani et al.,
2013). This side effect of 3-AP significantly limits its clinical
use, especially in patients with impaired cardiopulmonary
function. In the design of new anticancer agents, which will
be more efficient than 3-AP, it is very important to avoid this
side effect of 3-AP. According to the results of the in vitro
experiment, one can conclude that 3-AP was significantly morePlease cite this article in press as: Filipovic´, N.R. et al., Selenotriapine – An isostere
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studies have been reported that the redox-active complexes
of chelators and iron or copper ions, especially those with iron
ions, are more effective than chelators themselves in increasing
metHb generation (Basha et al., 2016; Quach et al., 2012).
Despite the structural similarity of Se-3-AP and 3-AP, the dif-
ferences between the redox-active complexes of Se-3-AP and 3-
AP, as well as different redox potentials could cause the differ-
ence in ability of the Se-3-AP and 3-AP to catalyze metHb for-
mation. Because Se-3-AP shows a lower ability for metHb
formation compared to 3-AP, it can be assumed that Se-3-
AP has more favorable toxicological profile than 3-AP, espe-
cially knowing that individuals with metHb content lower than
10% in blood serum do not show any clinical symptoms
(Adams et al., 2007).
HSA is the most abundant protein of blood plasma can
bind a remarkable variety of drugs impacting their delivery
and efficacy. HSA not only protects the bound drugs against
oxidation, but also alters the pharmacokinetic and pharmaco-
dynamics properties of drugs and influences the in vivo drug
distribution (Yang et al., 2014). In order to evaluate possibility
for Se-3-AP delivery with HSA through blood we investigated
Se-3-AP interaction with HSA. The results showed that Se-3-
AP quenches HSA intrinsic fluorescence in a concentration-
dependent manner, suggesting HSA–Se-3-AP adducts forma-
tion. The obtained values for Ksv and kq point out to the static
type mechanism of fluorophore quenching. The obtained neg-
ative value for DH and positive value for DS indicate that the
electrostatic forces are the main contributors to HSA–Se-3-AP
binding according to Ross’ view (Ross and Subramanian,
1981). The calculated kq values suggest that the binding
between Se-3-AP and HSA is moderate, which is also predicted
by the docking study. Results indicate that Se-3-AP can be
effectively transported and stored by HSA. As the values of
n at three different temperatures are very close to 1, Se-3-AP
binds only to one binding site of HSA.
Results of the Artemia salina lethality assay provide addi-
tional testimony to Se-3-AP favorable toxicity profile. This
assay is widely utilized model for evaluation of toxicity for
compounds of diverse structures and modes of activity, such
as anesthetics (Robinson et al., 1965), morphine-like com-
pounds (Richter and Goldstein, 1970), cocarcinogenicity of
phorbol esters (Kinghorn et al., 1977), pesticide residues
(Grosch, 1967), and new compounds with potentially thera-
peutic properties (Krstic et al., 2014; Vanhaecke et al., 1981).
Although results of Artemia salina lethality in context of com-
pounds with anticancer properties were usually discussed as
complementary indicator of the drug’s activity (Krstic et al.,
2014), those actually signify on its toxicity against non-
malignant cells. This experimental model has no established
cut-off LC50 value or grade scale that might be used for inter-
pretation of toxicity level for any investigated compound. Pre-
viously, Meyer et al. (1982) postulated that compounds with
LC50  1.0 mg/mL are known to possess toxic effects. How-
ever, due to variable sensitivity of Artemia species (Ruebhart
et al., 2008), treatment with K2Cr2O7 is usually used as an
internal control for evaluation of toxicity. Comparing current
LC50 for K2Cr2O7 and the one published by Meyer et al.
(1982) makes obvious that brine shrimps in our laboratory
revealed about fourfold higher sensitivity. This fact discards
the use of proposed LC50 concentration of 1 mg/mL for corre-
lation of Se-3-AP with other compounds. Nevertheless, farof the most studied thiosemicarbazone with pronounced pro-apoptotic activity,
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and Se-3-AP. While Se-3-AP induced significantly higher per-
centage of apoptotic cells on both THP-1 and MCF-7 cell lines
than 3-AP, its toxic activity on Artemia salina is twice lower.
These results clearly indicate that Se-3-AP most probably pos-
sesses certain level of selectivity toward malignant compared to
normal cells, which deserves detailed investigation in further
studies.
5. Conclusion
Summarizing, we synthesized and characterized a selenium
analog of 3-AP and investigated and compared biological
modes of action of two isosteres. Se-3-AP revealed as more
powerful apoptosis inducer than 3-AP, while both Se-3-AP
and 3-AP induced concentration-dependent changes in cell
cycle distribution. Apoptosis induced by Se-3-AP demon-
strated high level of caspases dependency with upstream acti-
vation of intrinsic pathway. Se-3-AP stimulated phenotype-
specific generation of mitochondrial O2
– and dissipation of
MTP in MCF-7 cells. Apart from its pro-apoptotic potential,
Se-3-AP also revealed ability to challenge phenotype repro-
gramming of 3-D breast cancer tumors. It caused
concentration-dependent changes in morphological features
and growth rate of treated spheroids, as well as down regula-
tion of Oct-4 gene expression. Se-3-AP showed lower ability
for metHb formation compared to 3-AP, while acute lethality
assay revealed its favorable toxicity profile. The presented data
merit Se-3-AP as a putative candidate for further clinical
development.
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